Ricardo Glover v. Kevin A. Carr

CourtCourt of Appeals for the Seventh Circuit
DecidedFebruary 6, 2020
Docket18-3028
StatusPublished

This text of Ricardo Glover v. Kevin A. Carr (Ricardo Glover v. Kevin A. Carr) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ricardo Glover v. Kevin A. Carr, (7th Cir. 2020).

Opinion

In the

United States Court of Appeals For the Seventh Circuit No. 18‐3028

RICARDO GLOVER, Plaintiff‐Appellant,

v.

KEVIN CARR, Secretary of the Wisconsin Department of Corrections, in his official capacity, et al., Defendants‐Appellees.

Appeal from the United States District Court for the Eastern District of Wisconsin. No. 2:16‐cv‐01048‐LA — Lynn Adelman, Judge.

ARGUED NOVEMBER 5, 2019 — DECIDED FEBRUARY 6, 2020

Before FLAUM, ROVNER, and HAMILTON, Circuit Judges. ROVNER, Circuit Judge. Ricardo Glover, a Wisconsin inmate, sued prison medical staff and Wisconsin Department of Corrections officials for deliberate indifference and for violat‐ ing his right to equal protection after they denied him medicine 2 No. 18‐3028

prescribed for post‐surgical erectile dysfunction. See 42 U.S.C. § 1983; Estelle v. Gamble, 429 U.S. 97, 104, 97 S. Ct. 285, 291 (1976) (deliberate indifference to a prisoner’s serious medical needs constitutes unnecessary and wanton infliction of pain proscribed by Eighth Amendment). Glover alleges that treatment of his erectile dysfunction was both necessary for penile rehabilitation and time sensitive in the sense that he was at risk of suffering permanent loss of erectile function if his condition was left untreated for too long following surgery. The defendants argued at summary judgment that the Depart‐ ment’s then‐current medical director was wholly responsible for the challenged decision, but Glover had sued only the former director and other uninvolved parties. Glover moved to substitute the new director as a defendant, but the court (twice) denied the motion. It entered summary judgment for the defendants on Glover’s claim for damages and then deemed his claim for injunctive relief voluntarily withdrawn, in order to finalize the decision for appeal. Glover appealed the judgment pro se. Following our review of the initial briefing, we appointed counsel to represent Glover, ordered re‐briefing, and set the case for argument. We now conclude that the district court abused its discretion by not allowing Glover to amend his complaint. We vacate the judgment and remand the case in order to allow Glover to proceed against the appropriate medical director in his individual capacity. We affirm the remainder of the judgment. I. In December 2015, while he was incarcerated with the Wisconsin Department of Corrections (“WDOC”), Glover was No. 18‐3028 3

diagnosed with an aggressive form of prostate cancer, and he elected to have surgery to remove his prostate the following month; since that time he has suffered from erectile dysfunc‐ tion. After the surgery, Glover’s off‐site urologist recom‐ mended that Glover medically rehabilitate his penile function by taking Cialis (tadalafil). To be clear, the purpose of this recommendation was to preserve Glover’s long‐term erectile function, as opposed to facilitating any sexual activity while Glover remained incarcerated.1 As noted, Glover alleges that he was at risk of losing his erectile function permanently if he did not receive timely treatment. Because Cialis was not on the WDOC’s formulary of approved medications, Glover’s prison physician instead prescribed Tolterodine, which addresses not erectile dysfunc‐

1 By way of background, we note that tadalafil is one of several phospho‐ diasterase type 5 (or PDE5) inhibitors which promote and prolong erections by increasing the flow of blood to the penis upon sexual stimulation. “PDE5 inhibitors are considered by most investigators and clinicians as the first‐ line treatment for [erectile dysfunction] after [radical prostatectomy], and remain the common element in most rehabilitation programs.” Ateş Kadio™lu, et al., Tadalafil therapy for erectile dysfunction following prostatectomy, 7(3) THERAPEUTIC ADVANCES IN UROLOGY 146, 150 (June 2015). PDE5 inhibitors like tadalafil are thought, but not known, to aid in penile rehabilitation by facilitating the delivery of oxygenated blood to the penile tissues, which in turn may help to preserve penile structures, length, and smooth muscle. Id. at 147–49. “There is little consensus on the optimal management [of post‐surgical erectile dysfunction]; however, it is agreed that treatment must be prompt to prevent fibrosis and increase oxygenation of penile tissue.” Alan Saleh, et al., Management of erectile dysfunction post‐ radical prostatectomy, 7 RESEARCH AND REPORTS IN UROLOGY 19, 19 (Feb. 2015); see also id. at 20. 4 No. 18‐3028

tion but urinary incontinence, another common side effect of prostate removal—and one which Glover initially experienced. But after Glover suffered from back pain while taking Toltero‐ dine, his prison physician wrote him a prescription for Cialis and completed a form requesting approval for the prescription notwithstanding its absence from the WDOC formulary.2 Dr. Ryan Holzmacher, the medical director of the WDOC’s Bureau of Health Services at all relevant times, co‐chaired the committee that decides which medications to list on the formulary, and he was responsible for reviewing requests for non‐formulary medication on a case‐by‐case basis. Glover’s request for Cialis was passed on to Dr. Holzmacher, who denied it. After a follow‐up examination, Glover’s urologist again recommended that Glover be prescribed Cialis for rehabilitation and preservation of his erectile function,3 and the prison physician followed suit. But Glover was never given the prescribed medication. After exhausting his administrative remedies, Glover sued prison medical staff and WDOC officials in their personal and official capacities, including Dr. Holzmacher’s predecessor, who personally played no role in these events. Glover alleged that they were deliberately indifferent to his erectile dysfunc‐ tion in violation of the Eighth Amendment. He also alleged that they violated his right to equal protection by treating him

2 Although the district court assumed that Cialis would be prescribed solely for erectile dysfunction, R.120 at 2 n. 1, there is nothing in the record indicating that Cialis was not part of a plan to treat all of Glover’s symp‐ toms, including urinary incontinence and erectile dysfunction.

3 By this time, Glover’s urinary continence had substantially improved. No. 18‐3028 5

worse than transgender inmates who received transition‐ related hormonal treatment. Glover sought damages and a preliminary and permanent injunction requiring the Depart‐ ment to provide him Cialis. The district court denied Glover’s motion for an emergency preliminary injunction without a hearing because, it determined, Glover was unlikely to establish that erectile dysfunction was a serious medical condition, as required to succeed on his deliberate indifference claim. R. 106 at 3. During discovery, Glover authorized the defendants to access his medical records. He later revoked that authorization, however, because he was convinced that they submitted to the court inauthentic, incomplete, and improperly redacted versions. The defendants moved for summary judgment. Regarding Glover’s deliberate indifference claim, they argued that Dr. Holzmacher, whom Glover did not sue, was responsible for denying the Cialis. They also asserted that erectile dysfunc‐ tion is not a serious medical need. Glover’s equal protection claim, they continued, failed because inmates with erectile dysfunction are not comparable to transgender inmates, so he had not shown that he was treated differently from similarly situated inmates. Glover then moved the district court to substitute Dr. Holzmacher for the former medical director as a defendant. Glover explained that the defendants had not informed him until summary judgment that Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Hafer v. Melo
502 U.S. 21 (Supreme Court, 1991)
Board of Trustees of Univ. of Ala. v. Garrett
531 U.S. 356 (Supreme Court, 2001)
Bausch v. Stryker Corp.
630 F.3d 546 (Seventh Circuit, 2010)
Roe v. Elyea
631 F.3d 843 (Seventh Circuit, 2011)
James Lyons v. RN/HSA Suzanne Brandly
430 F. App'x 377 (Sixth Circuit, 2011)
Arnett v. Webster
658 F.3d 742 (Seventh Circuit, 2011)
Dubicz v. Commonwealth Edison Company
377 F.3d 787 (Seventh Circuit, 2004)
Collins v. Illinois
554 F.3d 693 (Seventh Circuit, 2009)
Mark A. Campbell v. Kevin Kallas
936 F.3d 536 (Seventh Circuit, 2019)
Gutierrez v. Peters
111 F.3d 1364 (Seventh Circuit, 1997)
Michtavi v. Scism
808 F.3d 203 (Third Circuit, 2015)
Estate of Clark v. Walker
865 F.3d 544 (Seventh Circuit, 2017)
Watkins v. Trans Union, LLC
869 F.3d 514 (Seventh Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Ricardo Glover v. Kevin A. Carr, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ricardo-glover-v-kevin-a-carr-ca7-2020.